TELOID
LIVE

Serial Number

98855334

Owner

GemVax & KAEL Co., LTD.

Attorney

Jong Park

Filing Date

Nov 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TELOID Trademark

Serial Number: 98855334 • Registration: 7888158

TELOID is a trademark filed by GemVax & KAEL Co., LTD. on November 15, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GemVax & KAEL Co., LTD. (6 trademarks)

Daejeon 34036 , KR

Entity Type: 99

Trademark Details

Filing Date

November 15, 2024

Registration Date

August 12, 2025

Published for Opposition

June 24, 2025

Goods & Services

Research and development of vaccines and medicine; medicine research; medical and pharmacological research services; scientific research services for medical purposes in the field of oncology; development of pharmaceutical preparations and medicines; consultancy in analysis of biology sequence processing for medical research purposes; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; medical research laboratory services; scientific investigations for medical purposes; quality management services, namely, quality analysis and evaluation in the field of medical product development; drug discovery services; research on the subject of pharmaceuticals; medical research laboratory services; development of biological pharmaceutical preparations; research and development of amino acid for medical purpose; development of cell therapy products; laboratory research services relating to pharmaceuticals; scientific research for medical purposes in the field of cancerous diseases; conducting clinical studies of medicines for others; scientific research in the field of pharmacy; pharmaceutical research and development; biotechnology research; biomedical research services; pharmaceutical drug development; stem cell research services; pharmaceutical research services; consultancy in analysis of genomics for medical research purposes; basic and clinical research in the field of respiratory science and medicine; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical products evaluation; scientific research for medical purposes in the area of cancerous diseases; research and development of peptide for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 12, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 24, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 24, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 19, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 19, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 19, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 19, 2025 CNEA
ASSIGNED TO EXAMINER
May 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Dec 10, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 10, 2024 PARI
APPLICATION FILING RECEIPT MAILED
Nov 15, 2024 MAFR
NEW APPLICATION ENTERED
Nov 15, 2024 NWAP